Esperion Therapeutics Inc (NASDAQ:ESPR)
| 0.9948 Delayed Data As of Sep 22 |  -0.0952 / -8.73%Today’s Change | 0.85 Today|||52-Week Range 8.87 | -84.03% Year-to-Date |
Latest ESPR News | Press Releases
No recent news for Esperion Therapeutics Inc.
Today’s Trading
| Previous close | 1.09 |
| Today’s open | 1.09 |
| Day’s range | 0.85 - 1.09 |
| Volume | 302,149 |
| Average volume (3 months) | 3,238,794 |
| Market cap | $104.0M |
Data as of 4:00pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | +62.21% |
| Earnings growth (this year) | +36.28% |
| Earnings growth (next 5 years) | +46.80% |
| Revenue growth (last year) | -3.79% |
| P/E ratio | NM |
| Price/Sales | 5.48 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INOInovio Pharmaceutica... | -0.00 | -0.34% |
| DMACDiaMedica Therapeuti... | -0.18 | -6.00% |
| ORMPOramed Pharmaceutica... | -0.05 | -1.90% |
| ---- |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | October 31, 2023 |
| EPS forecast (this quarter) | -$0.49 |
| Annual revenue (last year) | $75.5M |
| Annual profit (last year) | -$233.7M |
| Net profit margin | -309.58% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Ann Arbor, Michigan |
Forecasts
